New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 (2022)
- Authors:
- Autor USP: PERON, JEAN PIERRE SCHATZMANN - ICB
- Unidade: ICB
- DOI: 10.1016/j.msard.2021.103321
- Subjects: IMUNOLOGIA; ESCLEROSE MÚLTIPLA; DOENÇAS DO SISTEMA NERVOSO CENTRAL; NEUROMIELITE ÓPTICA; DOENÇAS DO NERVO ÓPTICO; VACINAS VIRAIS; COVID-19
- Language: Inglês
- Imprenta:
- Source:
- Título: Multiple Sclerosis and Related Disorders
- ISSN: 2211-0356
- Volume/Número/Paginação/Ano: v. 57, art. 103321, p. 1-5, 2022
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
FRAGOSO, Yara Dadalti et al. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19. Multiple Sclerosis and Related Disorders, v. 57, p. 1-5, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.msard.2021.103321. Acesso em: 31 mar. 2026. -
APA
Fragoso, Y. D., Gomes, S., Gonçalves, M. V. M., Mendes Junior, E., Oliveira, B. E. S. de, Rocha, C. F., et al. (2022). New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19. Multiple Sclerosis and Related Disorders, 57, 1-5. doi:10.1016/j.msard.2021.103321 -
NLM
Fragoso YD, Gomes S, Gonçalves MVM, Mendes Junior E, Oliveira BES de, Rocha CF, Santos GAC dos, Tauil CB, Araujo RV, Peron JPS. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 [Internet]. Multiple Sclerosis and Related Disorders. 2022 ; 57 1-5.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1016/j.msard.2021.103321 -
Vancouver
Fragoso YD, Gomes S, Gonçalves MVM, Mendes Junior E, Oliveira BES de, Rocha CF, Santos GAC dos, Tauil CB, Araujo RV, Peron JPS. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 [Internet]. Multiple Sclerosis and Related Disorders. 2022 ; 57 1-5.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1016/j.msard.2021.103321 - Endostatin gene therapy inhibits intratumoral macrophage M2 polarization
- Zika virus-associated brain damage: animal models and open issues
- The diterpene from Sphagneticola trilobata (L.) Pruski, kaurenoic acid, reduces lipopolysaccharide-induced peritonitis and pain in mice
- Silencing of nuclear factor kappa b 1 gene expression inhibits colony formation, cell migration and invasion via the downregulation of interleukin 1 beta and matrix metallopeptidase 9 in renal cell carcinoma
- Direct and indirect impact of SARS-CoV-2 on the brain
- Zika virus congenital syndrome: experimental models and clinical aspects
- Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE
- Imunomodulação e neuroimunologia em modelos experimentais: encefalomielite autoimune e sindrome congênita do zika vírus
- The effect of low-level laser irradiation on sperm motility, and integrity of the plasma membrane and acrosome in cryopreserved bovine sperm
- Targeting adrenergic receptors to mitigate invariant natural killer T cells-induced acute liver injury
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
